There are strong data showing that malnutrition is highly prevalent in intensive care unit patients (20-50% in the worldwide), presenting a negative accumulated body energy balance. This results in an increased mortality, infections, and hospital length stay with high costs associated with the total treatment. Parenteral nutrition is the first option when the patient's physical condition is not suitable for oral nutrient intake. It is composed essentially by lipids as an energy source, metabolic, and structural function. However, these patients also require a mixture of essential and nonessential fatty acids (SMOF emulsions) to supply not only energy needs but also restore immunological, anti-inflammatory, and proregenerative functions. A revision of the safety and efficacy of Smoflipid® in patients requiring long-term parenteral nutrition was discussed here. Although controversial data are available indicating the contraindications or effectiveness of its use, most of studies presented indicate favorable benefits associated with improved clinical outcomes. The reported roles of this supplementation include positive immunomodulatory and anti-inflammatory effects, positive impact in liver function, reduction of hospital stay, and nosocomial infections as additional contributions to its energetic role, which in many cases results in reduced total costs per patient. Finally, many authors propose that the use of Smoflipid® should become a gold standard of parenteral nutrition in intensive unit care patients and that the costs associated with this supplement should not be limiting for its use, not only to improve the clinical outcome but also to reduce the treatment costs.

Centro de Biotecnología Universidad Técnica Federico Santa María Avenida España 1680 Valparaíso Chile

Institute of Physiology AS CR v v l Department of Mitochondrial Physiology Vídeňská 1083 14220 Prague 4 Czech Republic

Universidad Bernardo O Higgins Facultad de Salud Departamento de Ciencias Químicas y Biológicas Santiago Chile

See more in PubMed

Powers J., Samaan K. Malnutrition in the ICU patient population. Critical Care Nursing Clinics of North America. 2014;26(2):227–242. doi: 10.1016/j.ccell.2014.01.003. PubMed DOI

Singer P., Pichard C., Heidegger C. P., Wernerman J. Considering energy deficit in the intensive care unit. Current Opinion in Clinical Nutrition and Metabolic Care. 2010;13(2):170–176. doi: 10.1097/MCO.0b013e3283357535. PubMed DOI

Galindo Martín C. A., Ubeda Zelaya R. D. C., Monares Zepeda E., Lescas Méndez O. A. ROUNDS studies: relation of OUtcomes with nutrition despite severity-round one: ultrasound muscle measurements in critically ill adult patients. Journal of Nutrition and Metabolism. 2018;2018:7. doi: 10.1155/2018/7142325.7142325 PubMed DOI PMC

Lim S. L., Ong K. C., Chan Y. H., Loke W. C., Ferguson M., Daniels L. Malnutrition and its impact on cost of hospitalization, length of stay, readmission and 3-year mortality. Clinical Nutrition. 2012;31(3):345–350. doi: 10.1016/j.clnu.2011.11.001. PubMed DOI

Barker L. A., Gout B. S., Crowe T. C. Hospital malnutrition: prevalence, identification and impact on patients and the healthcare system. International Journal of Environmental Research and Public Health. 2011;8(2):514–527. doi: 10.3390/ijerph8020514. PubMed DOI PMC

Cotogni P. Management of parenteral nutrition in critically ill patients. World Journal of Critical Care Medicine. 2017;6(1):13–20. doi: 10.5492/wjccm.v6.i1.13. PubMed DOI PMC

Raman M., Almutairdi A., Mulesa L., Alberda C., Beattie C., Gramlich L. Parenteral nutrition and lipids. Nutrients. 2017;9(4):p. 388. doi: 10.3390/nu9040388. PubMed DOI PMC

Klek S. Omega-3 fatty acids in modern parenteral nutrition: a review of the current evidence. Journal of Clinical Medicine. 2016;5(3):p. 34. doi: 10.3390/jcm5030034. PubMed DOI PMC

Calder P. C., Jensen G. L., Koletzko B. V., Singer P., Wanten G. J. Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directions. Intensive Care Medicine. 2010;36(5):735–749. doi: 10.1007/s00134-009-1744-5. PubMed DOI PMC

Meisel J. A., Le H. D., de Meijer V. E., et al. Comparison of 5 intravenous lipid emulsions and their effects on hepatic steatosis in a murine model. Journal of Pediatric Surgery. 2011;46(4):666–673. doi: 10.1016/j.jpedsurg.2010.08.018. PubMed DOI

Singer P., Berger M. M., Van den Berghe G., et al. ESPEN guidelines on parenteral nutrition: intensive care. Clinical Nutrition. 2009;28(4):387–400. doi: 10.1016/j.clnu.2009.04.024. PubMed DOI

Chen W., Jiang H., Zhou Z. Y., et al. Is omega-3 fatty acids enriched nutrition support safe for critical ill patients? A systematic review and meta-analysis. Nutrients. 2014;6(6):2148–2164. doi: 10.3390/nu6062148. PubMed DOI PMC

Fell G. L., Nandivada P., Gura K. M., Puder M. Intravenous lipid emulsions in parenteral nutrition. Advances in Nutrition. 2015;6(5):600–610. doi: 10.3945/an.115.009084. PubMed DOI PMC

Gurr M. I. The role of lipids in human nutrition. In: Harwood J., Aparicio R., editors. Handbook of Olive Oil. Boston, MA, USA: Springer; 2000.

Gurr M. I., Harwood J. L., Frayn K. N. Lipid Biochemistry: An Introduction. 5th. Wiley-Blackwell; 1991.

Gurr M. I. Role of Fat in Food and Nutrition. 2nd. London, UK: Elsevier Applied Science; 1992.

Novák F., Borovská J., Vecka M., et al. Alterations in fatty acid composition of plasma and erythrocyte lipids in critically ill patients during sepsis. Casopís Lékar̆ů C̆eských. 2010;149(7):324–331. PubMed

Ott J., Hiesgen C., Mayer K. Lipids in critical care medicine. Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) 2011;85(5):267–273. doi: 10.1016/j.plefa.2011.04.011. PubMed DOI

Burke P. A., Ling P. R., Forse R. A., Bistrian B. R. Conditionally essential fatty acid deficiencies in end-stage liver disease. Nutrition. 1999;15(4):302–304. doi: 10.1016/s0899-9007(99)00002-7. PubMed DOI

Grimm H., Mertes N., Goeters C., et al. Improved fatty acid and leukotriene pattern with a novel lipid emulsion in surgical patients. European Journal of Nutrition. 2006;45(1):55–60. doi: 10.1007/s00394-005-0573-8. PubMed DOI

Mertes N., Grimm H., Fürst P., Stehle P. Safety and efficacy of a new parenteral lipid emulsion (SMOFlipid) in surgical patients: a randomized, double-blind, multicenter study. Annals of Nutrition and Metabolism. 2006;50(3):253–259. doi: 10.1159/000091683. PubMed DOI

Ma C. J., Sun L. C., Chen F. M. A double-blind randomized study comparing the efficacy and safety of a composite vs a conventional intravenous fat emulsion in postsurgical gastrointestinal tumor patients. Nutrition in Clinical Practice. 2012;27(3):410–415. doi: 10.1177/0884533611436115. PubMed DOI

Klek S., Chambrier C., Singer P. Four-week parenteral nutrition using a third generation lipid emulsion (SMOFlipid)—a double-blind, randomized, multicentre study in adults. Clinical Nutrition. 2013;32(2):224–231. doi: 10.1016/j.clnu.2012.06.011. PubMed DOI

Metry A. A., Abdelaal W., Ragaei M., Revaat M., Nakhala G. SMOFlipid versus intralipid in postoperative ISU patients. Enliven: Journal of Anesthesiology and Critical Care Medicine. 2014;1(6):p. 15. doi: 10.18650/2374-4448.16015. DOI

Wu M. H., Wang M. Y., Yang C. Y., Kuo M. L., Lin M. T. Randomized clinical trial of new intravenous lipid (SMOFlipid 20%) versus medium-chain triglycerides/long-chain triglycerides in adult patients undergoing gastrointestinal surgery. Journal of Parenteral and Enteral Nutrition. 2014;38(7):800–808. doi: 10.1177/0148607113512869. PubMed DOI

Mundi M. S., Martindale R. G., Hurt R. T. Emergence of mixed-oil fat emulsions for use in parenteral nutrition. Journal of Parenteral and Enteral Nutrition. 2017;41(1):3S–13S. doi: 10.1177/0148607117742595. PubMed DOI

Roberti G. J., Cangelose C. G., Martindale R. G. Composite intravenous fat emulsion in a postsurgical critically ill patient: a case report. Journal of Parenteral and Enteral Nutrition. 2017;41(1):14S–16S. doi: 10.1177/0148607117743494. PubMed DOI

Hurt R. T., Mundi M. S. Use of mixed-oil fat emulsion to improve intestinal failure-associated liver disease in long-term home parenteral nutrition: a case report. Journal of Parenteral and Enteral Nutrition. 2017;41(1):17S–19S. doi: 10.1177/0148607117741870. PubMed DOI

Lam K., Schiano T., Fiel M. I., Iyer K. Index use of Smoflipid in a tertiary intestinal rehabilitation and transplantation program. Journal of Parenteral and Enteral Nutrition. 2017;41(1):20S–23S. doi: 10.1177/0148607117743495. PubMed DOI

Kinikini M. Effect of measuring γ-glutamyl transpeptidase and using Smoflipid in a parenteral nutrition infusion in a patient with severe malabsorption and overlapping primary sclerosing cholangitis and ulcerative colitis. Journal of Parenteral and Enteral Nutrition. 2017;41(1):24S–27S. doi: 10.1177/0148607117742632. PubMed DOI

Choudhary N., Tan K., Malhotra A. Inpatient outcomes of preterm infants receiving ω-3 enriched lipid emulsion (SMOFlipid): an observational study. European Journal of Pediatrics. 2018;177(5):723–731. doi: 10.1007/s00431-018-3112-3. PubMed DOI

Bai H., Li Z., Meng Y., et al. Effects of parenteral ω-3 fatty acid supplementation in postoperative gastrointestinal cancer on immune function and length of hospital stay: a systematic review and meta-analysis. Asia Pacific Journal of Clinical Nutrition. 2018;27(1):121–128. doi: 10.6133/apjcn.022017.19. PubMed DOI

Pradelli L., Eandi M., Povero M., et al. Cost-effectiveness of omega-3 fatty acid supplements in parenteral nutrition therapy in hospitals: a discrete event simulation model. Clinical Nutrition. 2014;33(5):785–792. doi: 10.1016/j.clnu.2013.11.016. PubMed DOI

Feng Y., Li C., Zhang T., Pradelli L. Parenteral nutrition including an omega-3 fatty-acid-containing lipid emulsion for intensive care patients in China: a pharmacoeconomic analysis. ClinicoEconomics and Outcomes Research. 2017;9:547–555. doi: 10.2147/CEOR.S139902. PubMed DOI PMC

Leguina-Ruzzi A. A commentary on the 2015 canadian clinical practice guidelines in glutamine supplementation to parenteral nutrition. Critical Care. 2016;20(1):p. 7. doi: 10.1186/s13054-015-1175-3. PubMed DOI PMC

Pradelli L., Povero M., Muscaritoli M., Eandi M. Updated cost-effectiveness analysis of supplemental glutamine for parenteral nutrition of intensive-care patients. European Journal of Clinical Nutrition. 2015;69(5):546–551. doi: 10.1038/ejcn.2014.255. PubMed DOI PMC